Continuous glucose monitoring can identify unrecognized hyperglycemia and hypoglycemia in dialysis patients, challenging reliance on A1c for diabetes management.

Shares of DexCom slid after the company reported mixed third-quarter results that included disappointing new patient numbers and lower gross margin guidance. The stock fell 15% to $58.10 and is down ...

DexCom stock drops 15% despite strong Q3 and raised 2025 revenue outlook, as margin concerns and D7 product issues spark uncertainty for future growth. Read more here.

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information.

After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Research shows that more daytime movement in pregnant women with hyperglycemia can raise nighttime blood sugar, highlighting ...

Editor's Note: The YouTube outage has now been resolved. Read an update on Thursday, Oct. 16. YouTube experienced technical difficulties on Wednesday, Oct. 15, with hundreds of thousands of users ...

If you’re trying to figure out whether now’s the time to buy, hold, or even sell DexCom stock, you’re not alone. After all, its share price has been a bit of a roller coaster lately. Over the last ...

If I ever encounter device issues in Windows, say to my keyboard, printer, Bluetooth, USB, or audio playback I use the Microsoft Support Diagnostic Tool (MSDT) which can run diagnostic packs to ...

At a birthday party for Elon Musk in northern California wine country, late at night after cocktails, he and longtime friend Larry Page fell into an argument about the safety of artificial ...